Efficient	O
Reverse	B:C1657306
Genetic	I:C1657306
Systems	O
for	O
Rapid	O
Genetic	O
Manipulation	O
of	O
Emergent	O
and	O
Preemergent	O
Infectious	O
Coronaviruses	I:C0206750
.	O

Efficient	O
Reverse	O
Genetic	I:C1657306
Systems	O
for	O
Rapid	O
Genetic	O
Manipulation	O
of	O
Emergent	O
and	O
Preemergent	O
Infectious	B:C0206750
Coronaviruses	I:C0206750
.	O

Emergent	O
and	O
preemergent	O
coronaviruses	B:C0010076
(	O
coronaviruses	O
)	O
pose	O
a	O
global	O
threat	O
that	O
requires	O
immediate	O
intervention	O
.	O

Emergent	O
and	O
preemergent	O
coronaviruses	O
(	O
coronaviruses	B:C0010076
)	O
pose	O
a	O
global	O
threat	O
that	O
requires	O
immediate	O
intervention	O
.	O

Emergent	O
and	O
preemergent	O
coronaviruses	O
(	O
coronaviruses	O
)	O
pose	O
a	O
global	O
threat	O
that	O
requires	O
immediate	O
intervention	B:C0017296
.	O

Rapid	B:C0017296
intervention	I:C0017296
necessitates	O
the	O
capacity	O
to	O
generate	O
,	O
grow	O
,	O
and	O
genetically	O
manipulate	I:C0017387
infectious	O
CoVs	I:C0206750
in	O
order	O
to	O
rapidly	O
evaluate	O
pathogenic	O
mechanisms	O
,	O
host	O
and	I:C4277517
tissue	I:C4277517
permissibility	I:C4277517
,	O
and	O
candidate	O
antiviral	O
therapeutic	I:C0280274
efficacy	I:C0280274
.	O

Rapid	O
intervention	I:C0017296
necessitates	O
the	O
capacity	O
to	O
generate	O
,	O
grow	O
,	O
and	O
genetically	B:C0017387
manipulate	I:C0017387
infectious	O
CoVs	I:C0206750
in	O
order	O
to	O
rapidly	O
evaluate	O
pathogenic	O
mechanisms	O
,	O
host	O
and	I:C4277517
tissue	I:C4277517
permissibility	I:C4277517
,	O
and	O
candidate	O
antiviral	O
therapeutic	I:C0280274
efficacy	I:C0280274
.	O

Rapid	O
intervention	I:C0017296
necessitates	O
the	O
capacity	O
to	O
generate	O
,	O
grow	O
,	O
and	O
genetically	O
manipulate	I:C0017387
infectious	B:C0206750
CoVs	I:C0206750
in	O
order	O
to	O
rapidly	O
evaluate	O
pathogenic	O
mechanisms	O
,	O
host	O
and	I:C4277517
tissue	I:C4277517
permissibility	I:C4277517
,	O
and	O
candidate	O
antiviral	O
therapeutic	I:C0280274
efficacy	I:C0280274
.	O

Rapid	O
intervention	I:C0017296
necessitates	O
the	O
capacity	O
to	O
generate	O
,	O
grow	O
,	O
and	O
genetically	O
manipulate	I:C0017387
infectious	O
CoVs	I:C0206750
in	O
order	O
to	O
rapidly	O
evaluate	O
pathogenic	B:C3816499
mechanisms	O
,	O
host	O
and	I:C4277517
tissue	I:C4277517
permissibility	I:C4277517
,	O
and	O
candidate	O
antiviral	O
therapeutic	I:C0280274
efficacy	I:C0280274
.	O

Rapid	O
intervention	I:C0017296
necessitates	O
the	O
capacity	O
to	O
generate	O
,	O
grow	O
,	O
and	O
genetically	O
manipulate	I:C0017387
infectious	O
CoVs	I:C0206750
in	O
order	O
to	O
rapidly	O
evaluate	O
pathogenic	O
mechanisms	O
,	O
host	B:C4277517
and	I:C4277517
tissue	I:C4277517
permissibility	I:C4277517
,	O
and	O
candidate	O
antiviral	O
therapeutic	I:C0280274
efficacy	I:C0280274
.	O

Rapid	O
intervention	I:C0017296
necessitates	O
the	O
capacity	O
to	O
generate	O
,	O
grow	O
,	O
and	O
genetically	O
manipulate	I:C0017387
infectious	O
CoVs	I:C0206750
in	O
order	O
to	O
rapidly	O
evaluate	O
pathogenic	O
mechanisms	O
,	O
host	O
and	I:C4277517
tissue	I:C4277517
permissibility	I:C4277517
,	O
and	O
candidate	O
antiviral	B:C0280274
therapeutic	I:C0280274
efficacy	I:C0280274
.	O

coronaviruses	B:C0010076
encode	O
the	O
largest	O
viral	O
RNA	I:C0035736
genomes	O
at	O
about	O
28-	O
32,000	O
nucleotides	O
in	O
length	O
,	O
and	O
thereby	O
complicate	O
efficient	O
engineering	O
of	I:C0017387
the	I:C0017387
genome	I:C0017387
.	O

coronaviruses	O
encode	O
the	O
largest	O
viral	B:C0035736
RNA	I:C0035736
genomes	O
at	O
about	O
28-	O
32,000	O
nucleotides	O
in	O
length	O
,	O
and	O
thereby	O
complicate	O
efficient	O
engineering	O
of	I:C0017387
the	I:C0017387
genome	I:C0017387
.	O

coronaviruses	O
encode	O
the	O
largest	O
viral	O
RNA	I:C0035736
genomes	B:C0017428
at	O
about	O
28-	O
32,000	O
nucleotides	O
in	O
length	O
,	O
and	O
thereby	O
complicate	O
efficient	O
engineering	O
of	I:C0017387
the	I:C0017387
genome	I:C0017387
.	O

coronaviruses	O
encode	O
the	O
largest	O
viral	O
RNA	I:C0035736
genomes	O
at	O
about	O
28-	O
32,000	O
nucleotides	B:C0028630
in	O
length	O
,	O
and	O
thereby	O
complicate	O
efficient	O
engineering	O
of	I:C0017387
the	I:C0017387
genome	I:C0017387
.	O

coronaviruses	O
encode	O
the	O
largest	O
viral	O
RNA	I:C0035736
genomes	O
at	O
about	O
28-	O
32,000	O
nucleotides	O
in	O
length	O
,	O
and	O
thereby	O
complicate	O
efficient	O
engineering	B:C0017387
of	I:C0017387
the	I:C0017387
genome	I:C0017387
.	O

Deconstructing	B:C0017387
the	I:C0017387
genome	I:C0017387
into	O
manageable	O
fragments	O
affords	O
the	O
plasticity	O
necessary	O
to	O
rapidly	O
introduce	O
targeted	O
genetic	O
changes	I:C1705285
in	O
parallel	O
and	O
assort	O
mutated	O
fragments	O
while	O
maximizing	O
genome	O
stability	I:C1257825
over	O
time	O
.	O

Deconstructing	O
the	I:C0017387
genome	I:C0017387
into	O
manageable	O
fragments	B:C1704681
affords	O
the	O
plasticity	O
necessary	O
to	O
rapidly	O
introduce	O
targeted	O
genetic	O
changes	I:C1705285
in	O
parallel	O
and	O
assort	O
mutated	O
fragments	O
while	O
maximizing	O
genome	O
stability	I:C1257825
over	O
time	O
.	O

Deconstructing	O
the	I:C0017387
genome	I:C0017387
into	O
manageable	O
fragments	O
affords	O
the	O
plasticity	O
necessary	O
to	O
rapidly	O
introduce	O
targeted	O
genetic	B:C1705285
changes	I:C1705285
in	O
parallel	O
and	O
assort	O
mutated	O
fragments	O
while	O
maximizing	O
genome	O
stability	I:C1257825
over	O
time	O
.	O

Deconstructing	O
the	I:C0017387
genome	I:C0017387
into	O
manageable	O
fragments	O
affords	O
the	O
plasticity	O
necessary	O
to	O
rapidly	O
introduce	O
targeted	O
genetic	O
changes	I:C1705285
in	O
parallel	O
and	O
assort	O
mutated	B:C1513776
fragments	O
while	O
maximizing	O
genome	O
stability	I:C1257825
over	O
time	O
.	O

Deconstructing	O
the	I:C0017387
genome	I:C0017387
into	O
manageable	O
fragments	O
affords	O
the	O
plasticity	O
necessary	O
to	O
rapidly	O
introduce	O
targeted	O
genetic	O
changes	I:C1705285
in	O
parallel	O
and	O
assort	O
mutated	O
fragments	B:C1704681
while	O
maximizing	O
genome	O
stability	I:C1257825
over	O
time	O
.	O

Deconstructing	O
the	I:C0017387
genome	I:C0017387
into	O
manageable	O
fragments	O
affords	O
the	O
plasticity	O
necessary	O
to	O
rapidly	O
introduce	O
targeted	O
genetic	O
changes	I:C1705285
in	O
parallel	O
and	O
assort	O
mutated	O
fragments	O
while	O
maximizing	O
genome	B:C1257825
stability	I:C1257825
over	O
time	O
.	O

In	O
this	O
protocol	B:C2348563
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	B:C1657306
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	B:C0010076
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	B:C0042720
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	B:C0010076
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	B:C0017428
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	B:C0598888
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	B:C0032136
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	B:C1257825
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	O
.	O

In	O
this	O
protocol	O
we	O
describe	O
a	O
well	O
-	O
developed	O
reverse	O
genetic	I:C1657306
platform	I:C1657306
strategy	O
for	O
coronaviruses	O
that	O
is	O
comprised	O
of	O
partitioning	O
the	O
viral	O
genome	I:C0042720
into	O
5	O
-	O
7	O
independent	O
DNA	O
fragments	O
(	O
depending	O
on	O
the	O
CoV	O
genome	O
)	O
,	O
each	O
subcloned	O
into	O
a	O
plasmid	O
for	O
increased	O
stability	O
and	O
ease	O
of	O
genetic	O
manipulation	O
and	O
amplification	B:C0017256
.	O

Coronavirus	B:C0010076
genomes	O
are	O
conveniently	O
partitioned	O
by	O
introducing	O
type	O
IIS	I:C0012906
or	O
IIG	O
restriction	I:C0012906
enzyme	I:C0012906
recognition	O
sites	I:C1882940
that	O
confer	O
directional	O
cloning	I:C0598888
.	O

Coronavirus	O
genomes	B:C0017428
are	O
conveniently	O
partitioned	O
by	O
introducing	O
type	O
IIS	I:C0012906
or	O
IIG	O
restriction	I:C0012906
enzyme	I:C0012906
recognition	O
sites	I:C1882940
that	O
confer	O
directional	O
cloning	I:C0598888
.	O

Coronavirus	O
genomes	O
are	O
conveniently	O
partitioned	O
by	O
introducing	O
type	B:C0012906
IIS	I:C0012906
or	O
IIG	O
restriction	I:C0012906
enzyme	I:C0012906
recognition	O
sites	I:C1882940
that	O
confer	O
directional	O
cloning	I:C0598888
.	O

Coronavirus	O
genomes	O
are	O
conveniently	O
partitioned	O
by	O
introducing	O
type	O
IIS	I:C0012906
or	O
IIG	B:C0012906
restriction	I:C0012906
enzyme	I:C0012906
recognition	O
sites	I:C1882940
that	O
confer	O
directional	O
cloning	I:C0598888
.	O

Coronavirus	O
genomes	O
are	O
conveniently	O
partitioned	O
by	O
introducing	O
type	O
IIS	I:C0012906
or	O
IIG	O
restriction	I:C0012906
enzyme	I:C0012906
recognition	B:C1882940
sites	I:C1882940
that	O
confer	O
directional	O
cloning	I:C0598888
.	O

Coronavirus	O
genomes	O
are	O
conveniently	O
partitioned	O
by	O
introducing	O
type	O
IIS	I:C0012906
or	O
IIG	O
restriction	I:C0012906
enzyme	I:C0012906
recognition	O
sites	I:C1882940
that	O
confer	O
directional	B:C0598888
cloning	I:C0598888
.	O

Since	O
each	O
restriction	B:C1882940
site	I:C1882940
leaves	O
a	O
unique	O
overhang	O
between	O
adjoining	O
fragments	O
,	O
reconstruction	O
of	I:C0017387
the	I:C0017387
full	I:C0017387
-	I:C0017387
length	I:C0017387
genome	I:C0017387
can	O
be	O
achieved	O
through	O
a	O
standard	O
DNA	O
ligation	I:C1155649
comprised	O
of	O
equal	O
molar	O
ratios	O
of	O
each	O
fragment	O
.	O

Since	O
each	O
restriction	O
site	I:C1882940
leaves	O
a	O
unique	O
overhang	O
between	O
adjoining	O
fragments	B:C1704681
,	O
reconstruction	O
of	I:C0017387
the	I:C0017387
full	I:C0017387
-	I:C0017387
length	I:C0017387
genome	I:C0017387
can	O
be	O
achieved	O
through	O
a	O
standard	O
DNA	O
ligation	I:C1155649
comprised	O
of	O
equal	O
molar	O
ratios	O
of	O
each	O
fragment	O
.	O

Since	O
each	O
restriction	O
site	I:C1882940
leaves	O
a	O
unique	O
overhang	O
between	O
adjoining	O
fragments	O
,	O
reconstruction	B:C0017387
of	I:C0017387
the	I:C0017387
full	I:C0017387
-	I:C0017387
length	I:C0017387
genome	I:C0017387
can	O
be	O
achieved	O
through	O
a	O
standard	O
DNA	O
ligation	I:C1155649
comprised	O
of	O
equal	O
molar	O
ratios	O
of	O
each	O
fragment	O
.	O

Since	O
each	O
restriction	O
site	I:C1882940
leaves	O
a	O
unique	O
overhang	O
between	O
adjoining	O
fragments	O
,	O
reconstruction	O
of	I:C0017387
the	I:C0017387
full	I:C0017387
-	I:C0017387
length	I:C0017387
genome	I:C0017387
can	O
be	O
achieved	O
through	O
a	O
standard	O
DNA	B:C1155649
ligation	I:C1155649
comprised	O
of	O
equal	O
molar	O
ratios	O
of	O
each	O
fragment	O
.	O

Since	O
each	O
restriction	O
site	I:C1882940
leaves	O
a	O
unique	O
overhang	O
between	O
adjoining	O
fragments	O
,	O
reconstruction	O
of	I:C0017387
the	I:C0017387
full	I:C0017387
-	I:C0017387
length	I:C0017387
genome	I:C0017387
can	O
be	O
achieved	O
through	O
a	O
standard	O
DNA	O
ligation	I:C1155649
comprised	O
of	O
equal	O
molar	O
ratios	O
of	O
each	O
fragment	B:C0486805
.	O

Using	O
this	O
method	B:C0025663
,	O
recombinant	O
CoVs	O
can	O
be	O
rapidly	O
generated	O
and	O
used	O
to	O
investigate	O
host	O
range	O
,	O
gene	O
function	I:C0314627
,	O
pathogenesis	O
,	O
and	O
candidate	O
therapeutics	O
for	O
emerging	O
and	O
preemergent	O
coronaviruses	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Using	O
this	O
method	O
,	O
recombinant	O
CoVs	O
can	O
be	O
rapidly	O
generated	O
and	O
used	O
to	O
investigate	O
host	O
range	O
,	O
gene	B:C0314627
function	I:C0314627
,	O
pathogenesis	O
,	O
and	O
candidate	O
therapeutics	O
for	O
emerging	O
and	O
preemergent	O
coronaviruses	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Using	O
this	O
method	O
,	O
recombinant	O
CoVs	O
can	O
be	O
rapidly	O
generated	O
and	O
used	O
to	O
investigate	O
host	O
range	O
,	O
gene	O
function	I:C0314627
,	O
pathogenesis	B:C0699748
,	O
and	O
candidate	O
therapeutics	O
for	O
emerging	O
and	O
preemergent	O
coronaviruses	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Using	O
this	O
method	O
,	O
recombinant	O
CoVs	O
can	O
be	O
rapidly	O
generated	O
and	O
used	O
to	O
investigate	O
host	O
range	O
,	O
gene	O
function	I:C0314627
,	O
pathogenesis	O
,	O
and	O
candidate	O
therapeutics	B:C0087111
for	O
emerging	O
and	O
preemergent	O
coronaviruses	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Using	O
this	O
method	O
,	O
recombinant	O
CoVs	O
can	O
be	O
rapidly	O
generated	O
and	O
used	O
to	O
investigate	O
host	O
range	O
,	O
gene	O
function	I:C0314627
,	O
pathogenesis	O
,	O
and	O
candidate	O
therapeutics	O
for	O
emerging	O
and	O
preemergent	O
coronaviruses	B:C0010076
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

Using	O
this	O
method	O
,	O
recombinant	O
CoVs	O
can	O
be	O
rapidly	O
generated	O
and	O
used	O
to	O
investigate	O
host	O
range	O
,	O
gene	O
function	I:C0314627
,	O
pathogenesis	O
,	O
and	O
candidate	O
therapeutics	O
for	O
emerging	O
and	O
preemergent	O
coronaviruses	O
both	O
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
.	O

